tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ARWR Stock Latest News

Arrowhead says FDA accepts NDA for investigational plozasiran
The FlyArrowhead says FDA accepts NDA for investigational plozasiran
16h ago
ARWR
Sarepta’s Elevidys launch remains strong with solid beat, says JPMorgan
PremiumThe Fly
Sarepta’s Elevidys launch remains strong with solid beat, says JPMorgan
5d ago
ARWR
SRPT
Arrowhead doses 1st patients in study of ARO-INHBE for obesity treatment
PremiumThe Fly
Arrowhead doses 1st patients in study of ARO-INHBE for obesity treatment
26d ago
ARWR
Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright
PremiumThe Fly
Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright
29d ago
ARWR
IONS
Leadership Transition at Arrowhead Pharmaceuticals’ Board
PremiumCompany Announcements
Leadership Transition at Arrowhead Pharmaceuticals’ Board
1M ago
8K
ARWR
Arrowhead announces interim results from ARO-CFB study
PremiumThe FlyArrowhead announces interim results from ARO-CFB study
1M ago
ARWR
Arrowhead price target raised to $80 from $60 at H.C. Wainwright
Premium
The Fly
Arrowhead price target raised to $80 from $60 at H.C. Wainwright
2M ago
ARWR
SRPT
Arrowhead requests regulatory clearance to initiate ARO-ALK7 trial
Premium
The Fly
Arrowhead requests regulatory clearance to initiate ARO-ALK7 trial
2M ago
ARWR
Sarepta price target lowered to $75 from $80 at H.C. Wainwright
PremiumThe Fly
Sarepta price target lowered to $75 from $80 at H.C. Wainwright
2M ago
ARWR
SRPT
Arrowhead price target lowered to $24 from $27 at Bernstein
PremiumThe Fly
Arrowhead price target lowered to $24 from $27 at Bernstein
2M ago
ARWR
SRPT
Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance
PremiumCompany Announcements
Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance
2M ago
ARWR
Dell and HP forecasts spark selloffs: Morning Buzz
PremiumThe Fly
Dell and HP forecasts spark selloffs: Morning Buzz
2M ago
DKS
HPQ
Sarepta price target lowered to $202 from $205 at Needham
PremiumThe FlySarepta price target lowered to $202 from $205 at Needham
2M ago
ARWR
SRPT
Arrowhead price target lowered to $45 from $62 at Piper Sandler
Premium
The Fly
Arrowhead price target lowered to $45 from $62 at Piper Sandler
2M ago
ARWR
SRPT
Sarepta price target lowered to $182 from $200 at Piper Sandler
Premium
The Fly
Sarepta price target lowered to $182 from $200 at Piper Sandler
2M ago
ARWR
SRPT
Arrowhead price target lowered to $26 from $27 at Citi
PremiumThe Fly
Arrowhead price target lowered to $26 from $27 at Citi
2M ago
ARWR
Arrowhead Pharmaceuticals Eyes Future Growth with Strategic Deals
PremiumCompany Announcements
Arrowhead Pharmaceuticals Eyes Future Growth with Strategic Deals
2M ago
ARWR
Closing Bell Movers: Ambarella surges after earnings
PremiumThe Fly
Closing Bell Movers: Ambarella surges after earnings
2M ago
HPQ
AMBA
Arrowhead reports FY24 EPS ($5.00), consensus ($4.53)
PremiumThe Fly
Arrowhead reports FY24 EPS ($5.00), consensus ($4.53)
2M ago
ARWR
Sarepta price target raised to $217 from $210 at BofA
PremiumThe FlySarepta price target raised to $217 from $210 at BofA
2M ago
ARWR
SRPT
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
2M ago
HPQ
JWN
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
Premium
The Fly
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
2M ago
C
GS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >